From: Association of MRC-1 and IL-28Bwith the treatment outcome of hepatitis C: a case control study
HCV genotype 1 (HCV-1) | HCV genotype 2 (HCV-2) | |||||||
---|---|---|---|---|---|---|---|---|
All | SVR (+) | SVR (−) | Pvalue | All | SVR (+) | SVR (−) | Pvalue | |
Number of patients | 265 | 163 | 102 | - | 195 | 178 | 17 | - |
Sex (male/female) | 129/136 | 84/79 | 45/57 | 0.2 | 88/107 | 81/97 | 7/10 | 0.7 |
Mean age ± SD | 52.17 ± 10.27 | 50.69 ± 10.60 | 54.52 ± 9.29 | 0.002a | 51.62 ± 10.89 | 51.15 ± 11.16 | 56.47 ± 5.86 | 0.05a |
BMI (mean ± SD) | 24.6 ± 3.1 | 24.2 ± 2.9 | 25.2 ± 3.3 | 0.03a | 24.5 ± 3.5 | 24.5 ± 3.6 | 24.5 ± 2.7 | 0.9a |
Viral load (×10 6 ) | 12.1 ± 16.4 | 11.0 ± 16.5 | 13.9 ± 16.2 | 0.001a | 11.0 ± 19.0 | 10.3 ± 17.8 | 18.4 ± 27.9 | 0.3a |